These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21836628)

  • 21. Treatment of Macular Edema Due to Central Retinal Vein Occlusion: Another Score for Repackaged Bevacizumab.
    Bressler NM
    JAMA; 2017 May; 317(20):2067-2069. PubMed ID: 28492939
    [No Abstract]   [Full Text] [Related]  

  • 22. Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion: more data required.
    Hu K; Horgan SE; Sivaraj RR; Avgikos K
    Eye (Lond); 2010 Jan; 24(1):194; author reply 194-5. PubMed ID: 19218984
    [No Abstract]   [Full Text] [Related]  

  • 23. Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial.
    Prager F; Michels S; Kriechbaum K; Georgopoulos M; Funk M; Geitzenauer W; Polak K; Schmidt-Erfurth U
    Br J Ophthalmol; 2009 Apr; 93(4):452-6. PubMed ID: 19074916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spectral domain OCT documented resolution of recalcitrant macular edema after intravitreal bevacizumab in branch retinal vein occlusion.
    Chalam KV; Keshavamurthy R; Brar VS
    Eur J Ophthalmol; 2008; 18(5):831-3. PubMed ID: 18850569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination therapy with intravitreal bevacizumab and macular grid and scatter laser photocoagulation in patients with macular edema secondary to branch retinal vein occlusion.
    Yang CS; Liu JH; Chung YC; Chou YB; Hung KH
    J Ocul Pharmacol Ther; 2015 Apr; 31(3):179-85. PubMed ID: 25715024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravitreal bevacizumab (Avastin) as a treatment of the neovascular complications of laser-induced chorioretinal anastomosis for nonischaemic central retinal vein occlusion.
    Fong KC; Barry C; McAllister IL
    Clin Exp Ophthalmol; 2009 Jul; 37(5):485-9. PubMed ID: 19624345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion.
    Parveen S; Narayanan R; Sambhav K; Bhatia K
    Retina; 2010 Sep; 30(8):1324-5; author reply 1325. PubMed ID: 20827152
    [No Abstract]   [Full Text] [Related]  

  • 28. Central retinal vein occlusion in young women: rare cases with oral contraceptive pills as a risk factor.
    Thapa R; Paudyal G
    Nepal Med Coll J; 2009 Sep; 11(3):209-11. PubMed ID: 20334075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of ranibizumab alone versus ranibizumab with targeted retinal laser for branch retinal vein occlusion with macular edema.
    Goel S; Kumar A; Ravani RD; Chandra P; Chandra M; Kumar V
    Indian J Ophthalmol; 2019 Jul; 67(7):1105-1108. PubMed ID: 31238421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PERIPHERAL ISCHEMIC RETINAL PHOTOCOAGULATION IN ADDITION TO INTRAVITREAL BEVACIZUMAB VERSUS INTRAVITREAL BEVACIZUMAB ALONE FOR THE TREATMENT OF MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION: A Randomized Double-Masked Controlled Clinical Trial.
    Nourinia R; Emamverdi M; Ramezani A; Amizadeh Y; Khorshidifar M; Behnaz N; Safi S
    Retina; 2020 Jun; 40(6):1110-1117. PubMed ID: 31157710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative study of combined bevacizumab/targeted photocoagulation vs bevacizumab alone for macular oedema in ischaemic branch retinal vein occlusions.
    Tomomatsu Y; Tomomatsu T; Takamura Y; Gozawa M; Arimura S; Takihara Y; Inatani M
    Acta Ophthalmol; 2016 May; 94(3):e225-30. PubMed ID: 25989706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study.
    Kriechbaum K; Michels S; Prager F; Georgopoulos M; Funk M; Geitzenauer W; Schmidt-Erfurth U
    Br J Ophthalmol; 2008 Apr; 92(4):518-22. PubMed ID: 18211942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central Retinal Vein Occlusion: A Review of Current Evidence-based Treatment Options.
    Patel A; Nguyen C; Lu S
    Middle East Afr J Ophthalmol; 2016; 23(1):44-8. PubMed ID: 26957838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study.
    Costa RA; Jorge R; Calucci D; Melo LA; Cardillo JA; Scott IU
    Retina; 2007 Feb; 27(2):141-9. PubMed ID: 17290194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinal sensitivity after intravitreal injection of bevacizumab for the treatment of macular edema secondary to retinal vein occlusion.
    Yamaike N; Tsujikawa A; Sakamoto A; Ota M; Kotera Y; Miyamoto K; Kita M; Yoshimura N
    Retina; 2009 Jun; 29(6):757-67. PubMed ID: 19289982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bevacizumab in retinal vein occlusion-results of a prospective case series.
    Stahl A; Agostini H; Hansen LL; Feltgen N
    Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1429-36. PubMed ID: 17356824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion.
    Pai SA; Shetty R; Vijayan PB; Venkatasubramaniam G; Yadav NK; Shetty BK; Babu RB; Narayana KM
    Am J Ophthalmol; 2007 Apr; 143(4):601-6. PubMed ID: 17306753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comment on: 'Combination of peripheral laser photocoagulation with intravitreal bevacizumab in naive eyes with macular edema secondary to CRVO: prospective randomized study'.
    Călugăru D; Călugăru M
    Eye (Lond); 2016 Nov; 30(11):1520-1521. PubMed ID: 27285320
    [No Abstract]   [Full Text] [Related]  

  • 39. OCT patterns of macular edema and response to bevacizumab therapy in retinal vein occlusion.
    Hoeh AE; Ruppenstein M; Ach T; Dithmar S
    Graefes Arch Clin Exp Ophthalmol; 2010 Nov; 248(11):1567-72. PubMed ID: 20596719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease.
    Matsumoto Y; Freund KB; Peiretti E; Cooney MJ; Ferrara DC; Yannuzzi LA
    Retina; 2007; 27(4):426-31. PubMed ID: 17420693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.